Elevance Health insiders sell $6.7 million of stock, potentially signaling caution.
ByAinvest
Saturday, Aug 2, 2025 8:19 am ET1min read
ELV--
On the other hand, President Gail Boudreaux bought $2.4 million worth of shares, demonstrating optimism about the company's future. The total insider ownership stands at $77 million, or 0.1% of the company. This mixed activity could signal a cautious stance on the part of some insiders, but the recent purchase by the President suggests confidence in the company's prospects [1].
While insider transactions are not a definitive indicator of a stock's performance, they can provide valuable insights into the sentiment of those closest to the company. Investors should consider these transactions as part of their broader analysis of Elevance Health's stock.
References:
1. [NUMBER:1] https://www.marketbeat.com/instant-alerts/filing-vulcan-value-partners-llc-sells-15018-shares-of-elevance-health-inc-nyseelv-2025-08-01/
2. [NUMBER:2] https://finance.yahoo.com/news/elevance-health-insiders-sell-us-120032901.html
Elevance Health insiders sold $6.7m of stock in the past year, possibly signaling caution. The Executive VP & President of Commercial Health Benefits, Charles Kendrick, made the largest insider sale of $3.2m. However, President Gail Boudreaux bought $2.4m worth of shares, showing optimism about the company's future. Insider ownership stands at $77m, or 0.1% of the company.
Elevance Health Inc. (NYSE: ELV) has seen a mix of insider transactions over the past year, with some selling and others buying shares. According to recent filings, insiders have collectively sold $6.7 million worth of stock, while also making notable purchases. The Executive VP & President of Commercial Health Benefits, Charles Kendrick, made the largest insider sale, selling $3.2 million worth of shares at an average price of $432 each. This sale occurred above the latest price of $275, making it difficult to draw strong conclusions from it [1].On the other hand, President Gail Boudreaux bought $2.4 million worth of shares, demonstrating optimism about the company's future. The total insider ownership stands at $77 million, or 0.1% of the company. This mixed activity could signal a cautious stance on the part of some insiders, but the recent purchase by the President suggests confidence in the company's prospects [1].
While insider transactions are not a definitive indicator of a stock's performance, they can provide valuable insights into the sentiment of those closest to the company. Investors should consider these transactions as part of their broader analysis of Elevance Health's stock.
References:
1. [NUMBER:1] https://www.marketbeat.com/instant-alerts/filing-vulcan-value-partners-llc-sells-15018-shares-of-elevance-health-inc-nyseelv-2025-08-01/
2. [NUMBER:2] https://finance.yahoo.com/news/elevance-health-insiders-sell-us-120032901.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet